Covering IPOs, Healthcare and Technology Stocks

Andrei Zakharov

A highly collaborative investment professional and research analyst with 10+ years of international experience in equity research, treasury operations, and trading positions across multiple asset classes at leading multinational banks Citibank and Morgan Stanley, UHNWI-backed family office and European independent equity research firm. A respectable background in equity capital markets, corporate treasury, investment banking operations, equity research analysis and portfolio management.

MegaRobo Technologies IPO Preview: AI-Driven Robotics Unicorn With Strong IP Moat In Automation

MegaRobo: China-Based Disruptor in Life Science Automation

Equity Capital Markets

MegaRobo Technologies / Equity Capital Markets

<ul>
<li>MegaRobo Technologies files for Hong Kong IPO and seeks fresh funding to expand production capacity, accelerate R&amp;D efforts and improve working capital.</li>
<li>The rapidly growing autonomous agent provider in robotics applications in China did not disclose the proposed size and price range for the share sale in filings. </li>
<li>MegaRobo Technologies is enjoying healthy ~40% growth. I estimate the company’s TAM is ~$4.7B in 2024 and is expected to grow to ~$19B by 2030 only in China.</li>
</ul>


MegaRobo Technologies files for Hong Kong IPO and seeks fresh funding to expand production capacity, accelerate R&amp;D efforts and improve working capital.
The rapidly growing autonomous agent provider in robotics applications in China did not disclose the proposed size and price range for the share sale in filings. 
MegaRobo Technologies is enjoying healthy ~40% growth. I estimate the company’s TAM is ~$4.7B in 2024 and is expected to grow to ~$19B by 2030 only in China.


MegaRobo Technologies IPO Valuation Analysis: Headed For $1B+ Public Market Debut In Hong Kong